Clinical Trial Update: A Non-Interventional Safety Study of Balsamic Bactrim

View source ↗

Summary

A non-interventional safety study of Balsamic Bactrim sponsored by Hoffmann-La Roche has completed, evaluating safety in patients with bronchitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• Balsamic Bactrim (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Bronchitis | Status: COMPLETED